Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric PopulationPatricia D. Maglalang, Lauri Filar, Andrea N. Edginton et al.|Clinical Pharmacokinetics|2024Cited by 5
Population Pharmacokinetic Modeling of Oxcarbazepine and Its Active Metabolite 10-Monohydroxy Derivative to Inform Dosing in Children with ObesityJaydeep Sinha, Sasidharan Taravath, Kanecia O. Zimmerman et al.|Clinical Pharmacokinetics|2025Cited by 0